Inspection Record

Viva Pharmaceutical Inc. — Health Canada Inspection Findings

Health CanadaInspected 2025-09-22 11 findingsCleaning validationOther quality systemContamination controlDeviation, CAPA, and investigationEquipment and facilityLaboratory and QC controlsMaterial and supplier controlRegulatory reporting and change control

View the regulator's official source The source document is always the basis for judgement.

Findings

1Cleaning validation

The implementation and/or the effectiveness of the sanitation program in preventing unsanitary conditions was inadequate. The implementation, effectiveness, and/or validation of the cleaning procedures was inadequate for preventing unsanitary conditions. The premises were not designed, constructed, operated, and/or maintained to prevent contamination.

2Other quality system

The controls were inadequate for creating, modifying, reviewing, storing, and/or retrieving records.

3Contamination control

The implementation and/or the effectiveness of the sanitation program in preventing unsanitary conditions was inadequate. The premises were not designed, constructed, operated, and/or maintained to prevent contamination.

4Deviation, CAPA, and investigation

The traceability, legibility, documentation, formatting, and/or the accuracy of records was inadequate. Investigations into deviations, reports, and/or follow-up actions were inadequate. The maintenance of records was inadequate.

5Equipment and facility

The equipment was not set-up, designed, operated, stored, and/or maintained to prevent potential contamination of drugs by other drugs and/or by foreign material. The preventative maintenance program was inadequate for the equipment used in significant processing and/or testing operations.

6Laboratory and QC controls

The design, equipment, and/or maintenance of the testing laboratory was inadequate.

7Material and supplier control

The sampling plan for raw materials was inadequate.

8Equipment and facility

The maintenance of the premises was inadequate. The premises were not designed, constructed, operated, and/or maintained to allow clean and orderly conditions. The segregation, rotation of stock, and/or the transportation of raw materials, packaging materials, intermediates, bulk drugs, and/or finished products was inadequate.

9Regulatory reporting and change control

The change control system was inadequate for ensuring changes are properly documented, evaluated, and/or approved.

10Equipment and facility

The availability, content and/or maintenance of the quality agreements between the supplier, fabricator, tester, packager, labeller, distributor, importer, and/or wholesaler was inadequate.

11Other quality system

The recorded information or details were inadequate. The controls were inadequate for creating, modifying, reviewing, storing, and/or retrieving records.

About this record

Extracted automatically from the document of the Health Canada inspection on 2025-09-22. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Viva Pharmaceutical Inc. findings history — including this company's other documents Health Canada documents, 2025 Go to Findings search